19 results on '"Soini, EJ"'
Search Results
2. Watch Out for Berkson's Bias (BB)! Setting Health-Related Quality of Life (HRQOL) Treatment Targets with Matching-Adjusted Indirect Comparison (MAIC) in Order to Predict Matched General Population Control (MGPC) Targets, Assess Potential to Benefit (PTB) and Reveal Unmet Medical Need (UMN)
3. Icpc-2 Episode-Based Health-Related Quality Of Life And Three Months Effectiveness In Three Finnish Primary Health Care Settings
4. Comorbidity-Based Eq-5d Scores Of Primary Care Patients In Finland, Their Potential To Benefit And Unmet Medical Need
5. Disease Modifying Treatment (Dmt) is Associated with Lower Hazard for Death Among Multiple Sclerosis (Ms) Patients: Survival Analysis Based on 30 Years Incident Ms Cohort
6. Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland
7. Health Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine In Finnish Home Care Customers ≥50 Years With Underlying Chronic Medical Conditions
8. Cost-Effectiveness of First-Line Disease-Modifying Therapies (Dmts) For Relapsing-Remitting Ms (Rrms)
9. PHP253 - Icpc-2 Episode-Based Health-Related Quality Of Life And Three Months Effectiveness In Three Finnish Primary Health Care Settings
10. PHP226 - Comorbidity-Based Eq-5d Scores Of Primary Care Patients In Finland, Their Potential To Benefit And Unmet Medical Need
11. PHP184 - Health-Related Quality Of Life (Hrqol) Based On Preferences From 14 Countries In Primary Health Care Setting (Phcs)
12. PND15 - Disease Modifying Treatment (Dmt) is Associated with Lower Hazard for Death Among Multiple Sclerosis (Ms) Patients: Survival Analysis Based on 30 Years Incident Ms Cohort
13. PRM191 - Watch Out for Berkson's Bias (BB)! Setting Health-Related Quality of Life (HRQOL) Treatment Targets with Matching-Adjusted Indirect Comparison (MAIC) in Order to Predict Matched General Population Control (MGPC) Targets, Assess Potential to Benefit (PTB) and Reveal Unmet Medical Need (UMN)
14. PIN22 - Health Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine In Finnish Home Care Customers ≥50 Years With Underlying Chronic Medical Conditions
15. PND44 - Cost-Effectiveness of First-Line Disease-Modifying Therapies (Dmts) For Relapsing-Remitting Ms (Rrms)
16. PSY65 - Cost-Effectiveness of Ustekinumab In The Treatment of Psoriasis In Finland
17. Cost-effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients.
18. Cost-utility of first-line actinic keratosis treatments in Finland.
19. Cost-Utility of Vortioxetine in the Treatment of Major Depressive Disorder: Comparison with Agomelatine, Bupropion, Sertraline and Venlafaxine in the Finnish Setting.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.